An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line

References

• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• BildsteinLDubernetCMarsaudVTransmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathwayJ Control Release2010147216317020691740
   PubMed Web of Science ®Google Scholar
• GuoLFanLPangZTRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomesJ Control Release201115419310221609741
   PubMed Web of Science ®Google Scholar
• PeixotoRDHoMRenoufDJEligibility of metastatic pancreatic cancer patients for first-line palliative intent nab-paclitaxel plus gemcitabine versus FOLFIRINOXAm J Clin Oncol Epub201541
   PubMed Web of Science ®Google Scholar
• ConroyTDesseigneFYchouMGroupe Tumeurs Digestives of Unicancer; PRODIGE IntergroupFOLFIRINOX versus gemcitabine for metastatic pancreatic cancerN Engl J Med2011364191817182521561347
   PubMed Web of Science ®Google Scholar
• KingRSGemcitabine. New first-line therapy for pancreatic cancerCancer Pract1996463533549128490
   PubMedGoogle Scholar
• MoysanEBastiatGBenoitJPGemcitabine versus modified gemcitabine: a review of several promising chemical modificationsMol Pharm201310243044422978251
   PubMed Web of Science ®Google Scholar
• NakanoYTannoSKoizumiKGemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBr J Cancer200796345746317224927
   PubMed Web of Science ®Google Scholar
• AnderssonRAhoUNilssonBIGemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutionsScand J Gastroenterol200944778278619214867
   PubMed Web of Science ®Google Scholar
• ShengZHuDZhengMSmart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapyACS Nano2014812123101232225454579
   PubMed Web of Science ®Google Scholar
• KratzFA clinical update of using albumin as a drug vehicle – a commentaryJ Control Release201419033133624637463
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
   PubMed Web of Science ®Google Scholar
• GradisharWJAlbumin-bound paclitaxel: a next-generation taxaneExpert Opin Pharmacother2006781041105316722814
   PubMed Web of Science ®Google Scholar
• SchnitzerJEOhPAlbondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albuminsJ Biol Chem19942698607260828119952
   PubMed Web of Science ®Google Scholar
• TiruppathiCSongWBergenfeldtMSassPMalikABGp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathwayJ Biol Chem19972724125968259759325331
   PubMed Web of Science ®Google Scholar
• JohnTAVogelSMMinshallRDRidgeKTiruppathiCMalikABEvidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lungJ Physiol2001533pt 254755911389211
   PubMed Web of Science ®Google Scholar
• NeuzilletCTijeras-RaballandACrosJFaivreSHammelPRaymondEStromal expression of SPARC in pancreatic adenocarcinomaCancer Metastasis Rev2013323–458560223690170
   PubMed Web of Science ®Google Scholar
• HoangBErnstingMJRoyAMurakamiMUndzysELiSDDocetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanismBiomaterials201559667625956852
   PubMed Web of Science ®Google Scholar
• KratzFAlbumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
   PubMed Web of Science ®Google Scholar
• ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
   PubMed Web of Science ®Google Scholar
• Von HoffDDErvinTArenaFPIncreased survival in pancreatic cancer with nab-paclitaxel plus gemcitabineN Engl J Med2013369181691170324131140
   PubMed Web of Science ®Google Scholar
• Von HoffDDRamanathanRKBoradMJGemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trialJ Clin Oncol201129344548455421969517
   PubMed Web of Science ®Google Scholar
• LiCLiYGaoYDirect comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?Int J Pharm20144681–2152524709221
   PubMed Web of Science ®Google Scholar
• MonteroAJAdamsBDiaz-MonteroCMGluckSNab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive reviewExpert Rev Clin Pharmacol20114332933422114779
   PubMedGoogle Scholar
• YardleyDAnab-Paclitaxel mechanisms of action and deliveryJ Control Release2013170336537223770008
   PubMed Web of Science ®Google Scholar
• LiJMChenWWangHPreparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitroActa Pharmacol Sin20093091337134319730429
   PubMed Web of Science ®Google Scholar
• JiSXuJZhangBRGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapyCancer Biol Ther201213410
   Web of Science ®Google Scholar
• LiJDiYJinCGemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivoNanoscale Res Lett20138117623594566
   PubMed Web of Science ®Google Scholar
• KimTHJiangHHYounYSPreparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activityInt J Pharm20114031–228529121035530
   PubMed Web of Science ®Google Scholar
• SandovalMASloatBRLansakara-PDSEGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityJ Control Release2012157228729621871505
   PubMed Web of Science ®Google Scholar
• PaolinoDCoscoDRacanicchiLGemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activityJ Control Release2010144214415020184929
   PubMed Web of Science ®Google Scholar
• TaoXMWangJCWangJBEnhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivoEur J Pharm Biopharm201282240140922728546
   PubMed Web of Science ®Google Scholar
• FedericoCMorittuVMBrittiDTrapassoECoscoDGemcitabine-loaded liposomes: rationale, potentialities and future perspectivesInt J Nanomedicine201275423543623139626
   PubMed Web of Science ®Google Scholar
• WangLAnYYuanCGEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cellsInt J Nanomedicine2015102507251925848268
   PubMed Web of Science ®Google Scholar
• ChitkaraDKumarNBSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugsPharm Res20133092396240923756758
   PubMed Web of Science ®Google Scholar
• YangRAnYMiaoFLiMLiuPTangQPreparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivoInt J Nanomedicine201494231424325228802
   PubMed Web of Science ®Google Scholar
• DubeyRDAlamNSanejaADevelopment and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabineInt J Pharm20154921–2809126165611
   PubMedGoogle Scholar
• Yin WinKFengS-SEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials200526152713272215585275
   PubMed Web of Science ®Google Scholar
• SykesEAChenJZhengGChanWCInvestigating the impact of nanoparticle size on active and passive tumor targeting efficiencyACS Nano2014865696570624821383
   PubMed Web of Science ®Google Scholar
• StellaBArpiccoSRoccoFEncapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsulesInt J Pharm20073441–2717717651931
   PubMed Web of Science ®Google Scholar
• FangYDuFXuYEnhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsulesColloids Surf B Biointerfaces201512835736225746328
   PubMed Web of Science ®Google Scholar
• PrattSEDurland-BusbiceSShepardRLHeinz-TahenyKIversenPWDantzigAHHuman carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cellsClin Cancer Res20131951159116823325581
   PubMed Web of Science ®Google Scholar
• ElsadekBKratzFImpact of albumin on drug delivery – new applications on the horizonJ Control Release2012157142821959118
   PubMed Web of Science ®Google Scholar
• MisakHEAsmatuluRGopuJSAlbumin-based nanocomposite spheres for advanced drug delivery systemsBiotechnol J20149116317024106002
   PubMed Web of Science ®Google Scholar